Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective dose of ciprofol for BIS control during endotracheal intubation
ChiCTR2300068534Phase 4Not yet recruiting
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Mar 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol, sponsored by Tongde Hospital of Zhejiang Province. Primary endpoint: Bispectral Index (BIS). Planned start Mar 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300068534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068534.